OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The E3 Ligase TRIM4 Facilitates SET Ubiquitin‐Mediated Degradation to Enhance ER‐α Action in Breast Cancer
Dianwen Han, Lijuan Wang, Li Long, et al.
Advanced Science (2022) Vol. 9, Iss. 25
Open Access | Times Cited: 18

Showing 18 citing articles:

COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk
Xi Chen, Chenao Ma, Yaming Li, et al.
Oncogene (2024) Vol. 43, Iss. 23, pp. 1742-1756
Open Access | Times Cited: 6

Association of Proteasome Activity and Pool Heterogeneity with Markers Determining the Molecular Subtypes of Breast Cancer
И. В. Кондакова, E. E. Sereda, E. A. Sidenko, et al.
Cancers (2025) Vol. 17, Iss. 1, pp. 159-159
Open Access

Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
A. Awan, Maryiam Jama Ali Osman, Omar M. Khan
Cells (2025) Vol. 14, Iss. 2, pp. 69-69
Open Access

A multi-tissue, splicing-based joint transcriptome-wide association study identifies susceptibility genes for breast cancer
Guimin Gao, Julian McClellan, Alvaro Barbeira, et al.
The American Journal of Human Genetics (2024) Vol. 111, Iss. 6, pp. 1100-1113
Open Access | Times Cited: 4

Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4+T cell activation in breast cancer
Xi Chen, Chenao Ma, Yaming Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 3

Dysregulation of deubiquitination in breast cancer
Lili Kong, Xiaofeng Jin
Gene (2024) Vol. 902, pp. 148175-148175
Closed Access | Times Cited: 2

The next decade of SET: from an oncoprotein to beyond
Han Yao, Meng Zhang, Donglai Wang
Journal of Molecular Cell Biology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4

USP7 interacts with and destabilizes oncoprotein SET
Jianyuan Chen, Zishan Jiao, Yajing Liu, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 709, pp. 149818-149818
Closed Access | Times Cited: 1

Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer
Jianing Cao, Mengdi Yang, Duancheng Guo, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 1

The crosstalk between ubiquitination and endocrine therapy
Yidong Ge, Ziqing Zhan, Meng Ye, et al.
Journal of Molecular Medicine (2023) Vol. 101, Iss. 5, pp. 461-486
Closed Access | Times Cited: 2

The TRIM4 E3 ubiquitin ligase degrades TPL2 and is modulated by oncogenic KRAS
Sapana Bansod, Paarth B. Dodhiawala, Yutong Geng, et al.
Cell Reports (2024) Vol. 43, Iss. 9, pp. 114667-114667
Open Access

Multifaceted role of TRIM28 in health and disease
Mazaher Maghsoudloo, Khatere Mokhtari, Behdokht Jamali, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access

Post-translational modifications in drug resistance
Chenggui Miao, Yu Huang, Cheng Zhang, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101173-101173
Closed Access

TRIM4 enhances small-molecule-induced neddylated-degradation of CORO1A for triple negative breast cancer therapy
Wenjie Gu, Xiaoxia Liu, Yiwen Shen, et al.
Theranostics (2024) Vol. 14, Iss. 18, pp. 7023-7041
Open Access

Page 1

Scroll to top